GLP-1 weight-loss drugs, such as Ozempic, are revolutionizing the way consumers eat, prompting food and beverage manufacturers to develop precision nutrition solutions.
These solutions utilize AI and functional ingredients to personalize diets and target metabolism more effectively.
Precision nutrition involves aligning food intake with individual biological, metabolic, and behavioral characteristics.
Precision nutrition is about aligning what we eat with who we are – biologically, metabolically and behaviourally.
The weight-loss revolution sparked by GLP-1 drugs like Ozempic and Mounjaro is transforming the food industry's relationship with biology.
As consumers re-evaluate their eating habits, precision nutrition is gaining momentum as a parallel movement.
Author's summary: GLP-1 drugs drive precision nutrition.